As a part of the study, which was published in ‘Circulation: Cardiovascular Genetics’, numerous international scientists evaluated blood samples from just under 16,000 individuals: roughly 2,400 active smokers, 6,500 former smokers and almost 7,000 people who had never smoked. The Germans contributed data collected from 1,800 participants in the Augsburg KORA study.*
“By analyzing this large volume of data we were able to show that smoking leaves a type of epigenetic** fingerprint behind that can still be detected years later,” Dr. Melanie Waldenberger reports. She is a group leader in the Research Unit of Molecular Epidemiology at the Helmholtz Zentrum München and was involved in the study. According to the authors, some of these changes could even still be detected 30 years after the test subject had quit smoking. “Seen at the molecular level, this fingerprint involves methyl groups that are added to individual bases where they can influence the activity of the genes below.”
The scientists determined that this was the case for more than 1,000 genes, or about every 20th of the roughly 20,000 currently known. According to the authors, these include numerous genes that are relevant for pulmonary function and that also play a role in cancer, cardiovascular diseases and inflammation. “Some of these had already been associated with smoking, while others were new in this context,” says Prof. Annette Peters, Director of the Institute of Epidemiology. “Our hope is that it will be possible to derive disease mechanisms and consequently to create new treatments.”
The authors also have some encouraging news for those who would like to quit smoking: “Five years after smoking cessation, the majority of the methylation signals return to the levels of those who have never smoked,” says Dr. Rui Wang-Sattler, also a group leader in the Research Unit of Molecular Epidemiology.
*Key topics of the KORA studies are issues regarding the genesis and progress of chronic diseases, particularly cardiac infarction and diabetes mellitus. Risk factors from the area of health-related behaviour (such as smoking, nutrition, and physical activity), environmental factors (including air and noise pollution) and genetics are investigated for this purpose. From the point of view of care research, issues of the utilization and costs of healthcare are examined. Overall, the KORA research is intended to serve the development of new approaches in the area of chronic disease prevention and the improvement of healthcare.
** Epigenetics: In contrast to genetics, the term epigenetics refers to the inheritance of traits that are not determined in the primary sequence of the DNA (the genes). So far, RNA transcripts and chemical modifications of the chromatin (e.g. on the DNA or the histones) have been considered as carriers of this epigenetic information.
Original Publication: Joehanes, R. et al. (2016): Epigenetic Signatures of Cigarette Smoking. Circulation: Cardiovascular Genetics, doi: 10.1161/CIRCGENETICS.116.001506
The Helmholtz Zentrum München, the German Research Center for Environmental Health, pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München is headquartered in Neuherberg in the north of Munich and has about 2,300 staff members. It is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.
The Research Unit of Molecular Epidemiology (AME) analyses population-based cohorts and case studies for specific diseases, using genomics, epigenomics, transcriptomics, proteomics, metabolomics and functional analyses. The aim of this research unit is to decipher the molecular mechanisms of complex diseases like type 2 diabetes or obesity. The unit administers the biological specimen repository of the Department of Epidemiology and stores the samples for national and international projects.
The Institute of Epidemiology II (EPI II) focuses on the assessment of environmental and lifestyle risk factors which jointly affect major chronic diseases such as diabetes, heart disease and mental health. Research builds on the unique resources of the KORA cohort, the KORA myocardial infarction registry, and the KORA aerosol measurement station. Aging-related phenotypes have been added to the KORA research portfolio within the frame of the Research Consortium KORA-Age. The institute’s contributions are specifically relevant for the population as modifiable personal risk factors are being researched that could be influenced by the individual or by improving legislation for the protection of public health.
For almost 30 years, the Cooperative Health Research in the Region of Augsburg (KORA) has been examining the health of thousands of citizens in Augsburg and environs. The aim of the project is to increase understanding of the impact of environmental factors, behaviour and genes on human health. The KORA studies focus on matters relating to the development and progression of chronic diseases, in particular myocardial infarction and diabetes mellitus. To that end, research is conducted into risk factors arising from lifestyle factors (including smoking, diet and exercise), environmental factors (including air pollution and noise) and genetics. Questions relating to the use and cost of health services are examined from the point of view of health services research.